Recurrent hyponatremia associated with sertraline and lofepramine.
Bouman
W P
WP
Johnson
H
H
Trescoli-Serrano
C
C
Jones
R G
RG
D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced*; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008127:Lofepramine / Q000009:adverse effects*; D012008:Recurrence; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline
D015057:1-Naphthylamine; D000929:Antidepressive Agents, Tricyclic; D008127:Lofepramine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline